CA
XBI icon

Cumberland Advisors’s SPDR S&P Biotech ETF XBI Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-170,790
Closed -$13.5M 60
2022
Q3
$13.5M Sell
170,790
-6,735
-4% -$534K 5.39% 6
2022
Q2
$13.2M Sell
177,525
-138,790
-44% -$10.3M 4.38% 6
2022
Q1
$28.4M Buy
316,315
+63,101
+25% +$5.67M 6.59% 3
2021
Q4
$28.4M Sell
253,214
-4,100
-2% -$459K 5.94% 3
2021
Q3
$32.3M Buy
257,314
+20,055
+8% +$2.52M 7.48% 2
2021
Q2
$32.1M Buy
237,259
+66,018
+39% +$8.94M 7.54% 2
2021
Q1
$23.2M Buy
171,241
+3,216
+2% +$436K 5.76% 3
2020
Q4
$23.7M Buy
+168,025
New +$23.7M 8.66% 2
2020
Q2
$13.5M Sell
120,269
-87,240
-42% -$9.77M 5.1% 6
2020
Q1
$16.1M Sell
207,509
-645
-0.3% -$49.9K 6.55% 4
2019
Q4
$19.8M Sell
208,154
-2,905
-1% -$276K 6.82% 4
2019
Q3
$16.1M Buy
211,059
+5,230
+3% +$399K 4.55% 6
2019
Q2
$18.1M Sell
205,829
-3,250
-2% -$285K 6.09% 5
2019
Q1
$18.9M Buy
209,079
+23,660
+13% +$2.14M 6.56% 5
2018
Q4
$13.3M Buy
185,419
+128,779
+227% +$9.24M 4.77% 7
2018
Q3
$5.43M Buy
56,640
+13,420
+31% +$1.29M 3.63% 11
2018
Q2
$4.11M Buy
43,220
+1,270
+3% +$121K 2.57% 18
2018
Q1
$3.68M Buy
41,950
+290
+0.7% +$25.4K 2.25% 21
2017
Q4
$3.54M Buy
41,660
+37,560
+916% +$3.19M 1.95% 23
2017
Q3
$355K Sell
4,100
-60
-1% -$5.2K 0.22% 40
2017
Q2
$321K Hold
4,160
0.19% 42
2017
Q1
$288K Sell
4,160
-1,300
-24% -$90K 0.18% 36
2016
Q4
$323K Buy
+5,460
New +$323K 0.23% 35
2016
Q2
Sell
-38,160
Closed -$1.97M 57
2016
Q1
$1.97M Buy
+38,160
New +$1.97M 1.36% 20
2013
Q4
Sell
-25,990
Closed -$3.36M 40
2013
Q3
$3.36M Buy
25,990
+6,030
+30% +$779K 1.99% 15
2013
Q2
$2.08M Buy
+19,960
New +$2.08M 1.14% 32